1. Home
  2. TLX vs BFH Comparison

TLX vs BFH Comparison

Compare TLX & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • BFH
  • Stock Information
  • Founded
  • TLX 2015
  • BFH 1996
  • Country
  • TLX Australia
  • BFH United States
  • Employees
  • TLX N/A
  • BFH N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • BFH Business Services
  • Sector
  • TLX Health Care
  • BFH Consumer Discretionary
  • Exchange
  • TLX Nasdaq
  • BFH Nasdaq
  • Market Cap
  • TLX 3.2B
  • BFH 3.1B
  • IPO Year
  • TLX N/A
  • BFH N/A
  • Fundamental
  • Price
  • TLX $9.38
  • BFH $61.81
  • Analyst Decision
  • TLX Strong Buy
  • BFH Hold
  • Analyst Count
  • TLX 3
  • BFH 13
  • Target Price
  • TLX $21.33
  • BFH $60.17
  • AVG Volume (30 Days)
  • TLX 257.4K
  • BFH 491.1K
  • Earning Date
  • TLX 01-01-0001
  • BFH 10-23-2025
  • Dividend Yield
  • TLX N/A
  • BFH 1.33%
  • EPS Growth
  • TLX N/A
  • BFH N/A
  • EPS
  • TLX 0.04
  • BFH 5.76
  • Revenue
  • TLX $664,225,558.00
  • BFH $2,452,000,000.00
  • Revenue This Year
  • TLX N/A
  • BFH $59.65
  • Revenue Next Year
  • TLX N/A
  • BFH $4.18
  • P/E Ratio
  • TLX $220.22
  • BFH $10.75
  • Revenue Growth
  • TLX 55.35
  • BFH N/A
  • 52 Week Low
  • TLX $8.93
  • BFH $38.21
  • 52 Week High
  • TLX $30.36
  • BFH $68.01
  • Technical
  • Relative Strength Index (RSI)
  • TLX 36.10
  • BFH 44.21
  • Support Level
  • TLX $9.14
  • BFH $62.57
  • Resistance Level
  • TLX $9.53
  • BFH $64.65
  • Average True Range (ATR)
  • TLX 0.24
  • BFH 1.72
  • MACD
  • TLX 0.10
  • BFH -0.50
  • Stochastic Oscillator
  • TLX 25.71
  • BFH 6.20

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

Share on Social Networks: